Qube Research & Technologies (QRT)’s Novo Nordisk NVO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.7M	Sell	888,500 -777,600	-47%	-$36.8M	0.04%	612
2025 Q4	$84.8M	Buy	1,666,100 +465,600	+39%	+$23.8M	0.09%	303
2025 Q3	$66.6M	Buy	1,200,500 +320,100	+36%	+$18.7M	0.07%	357
2025 Q2	$60.8M	Buy	880,400 +425,600	+94%	+$28.9M	0.06%	408
2025 Q1	$31.6M	Buy	454,800 +192,500	+73%	+$15.9M	0.04%	563
2024 Q4	$22.6M	Buy	262,300 +102,100	+64%	+$11M	0.03%	672
2024 Q3	$19.1M	Buy	160,200 +121,000	+309%	+$16.1M	0.03%	699
2024 Q2	$5.6M	Buy	+39,200	New	+$5.19M	0.01%	1212
2024 Q1	–	Sell	-17,400	Closed	-$1.8M	–	4745
2023 Q4	$1.8M	Buy	+17,400	New	+$1.72M	﹤0.01%	1576

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NVO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 171,416 shares — an estimated $8.12M sold.

Qube Research & Technologies (QRT) first reported a position in NVO in Q1 2018 and held it in 20 quarters. The position peaked at $104M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Qube Research & Technologies (QRT) reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 171,416 Novo Nordisk shares in Q1 2026, an estimated $8.12M.
Qube Research & Technologies (QRT) first reported a position in Novo Nordisk in Q1 2018 and held it in 20 quarters.
Qube Research & Technologies (QRT)'s Novo Nordisk position peaked at $104M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.